FDA COMPREHENSIVE HAZARDOUS WASTE MANAGEMENT SERVICES Solicitation ID/Procurement Identifier: 75F40123R00003 Ultimate Completion Date: Wed Dec 29 18:00:00 GMT 2027
PHILADELPHIA LABORATORY CLOSURE-FDA COMPREHENSIVE HAZARDOUS WASTE MANAGEMENT SERVICES Solicitation ID/Procurement Identifier: 75F40123D00004 Ultimate Completion Date: Sat Sep 30 17:00:00 GMT 2023
The actual PoP will be determined at time of award.The objective of this Purchase Order is to procure a comprehensive internal communications assessment performed off-premises (remotely) in support of the U.S.
The FDA Approved Film Array Panel tests for a comprehensive set of pathogens. These panels aid inquickly identifying the correct pathogen and ensure appropriate treatment, patientmanagement and help decrease infectious diseases which can lead to severe illness or death. Vendor must meet the following requirements: 1. The kits must be compatible with the Bio Fire Film Array Instrumentation Model#FLM2-ASY-0001 2.
All brand name custom sterile procedure pack assembly, packaging and sterilization must adhere to the quality control standards established by the Food and Drug Administration (FDA). A comprehensive list of actual requirements will be included in the attached Statement of Work and within the solicitation document. The period of performance for this requirement consists of one (1), two (2)-year base contract with ordering periods.
registered, Medial CE Class 1, ISO 13485 certified comprehensive neurofeedback/biofeedback (NFB/BFB) device/system.
:Janssen (J&J) COVID-19 VaccineModerna COVID-19 Vaccine and Moderna COVID-19 Vaccine, BivalentNovavax COVID-19 Vaccine, AdjuvantedPfizer-BioNTech COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, BivalentAs with all vaccines and other medical products, although the vaccine development process and FDA’s evaluation are rigorous and comprehensive, after a vaccine for COVID-19 is authorized under EUA by FDA, or following licensure (approval) of a
